TEMPOL is one such example and has been shown to inhibit both hypoxia-inducible factor 1α (HIF-1α) and hypoxia-inducible factor 2 α(HIF-2α) in glioblastoma (54). This evidence concerns the gene EPAS1 and glioblastoma.